Orygen initiates project to build factory in Brazil

The joint venture between Biolab and Eurofarma closed a partnership with the American Pfizer for technology transfer and development of Biosimilar medicines for treatment of complex diseases. With this agreement, you may remove your paper Orygen project, about $ 500 million for construction of a factory to nationalize the production of these drugs. With the plan, the future factory due to come into operation in 2016 and can be built in the interior of Sao Paulo. The first medicines should be produced from 2018, according to the President of the company, Andrew Simpson.